You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carboplatin

Showing 1 - 25 of 1,578
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)

Recruiting
  • Advanced Solid Tumors
  • Debio 0123
  • Carboplatin
  • Groningen, Netherlands
  • +3 more
Aug 19, 2022

Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Sep 29, 2022

NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • (no location specified)
Jan 18, 2023

Breast Tumor Trial in Shanghai (Decitabine, Carboplatin)

Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022

NSCLC Trial in Seoul (Atezolizumab(Tecentriq), Pemetrexed, Bevacizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Gangnamgu, Korea, Republic of
    Samsung Medical Center
Dec 27, 2021

Adenocarcinoma of Lung, NSCLC Trial in Rolling Meadows (LP-300, Pemetrexed, Carboplatin)

Not yet recruiting
  • Adenocarcinoma of Lung
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 8, 2022

Gynecologic Malignancies Trial in Cleveland (Paclitaxel, Carboplatin)

Terminated
Has Results
  • Gynecologic Malignancies
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jun 29, 2022

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • Carboplatin
  • (no location specified)
Jun 22, 2022

Breast Cancer Trial in New York (Carboplatin, Everolimus)

Recruiting
  • Breast Cancer
  • New York, New York
  • +2 more
Oct 22, 2021

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Seattle

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Carboplatin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 10, 2022

Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Cincinnati, Ohio
  • +2 more
Apr 6, 2022

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Carboplatin
  • +3 more
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • Carboplatin
  • (no location specified)
Jul 11, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Carboplatin
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Jun 28, 2022

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

Triple-negative Breast Cancer Trial in Shanghai (chidamide, camrelizumab, carboplatin)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2022

Metastatic Medulloblastoma, High Risk Supratentorial PNET, Metastatic PNET Trial in Aurora (Carboplatin, Vincristine, 24 Gy)

Completed
Has Results
  • Metastatic Medulloblastoma
  • +2 more
  • Carboplatin
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
Dec 13, 2021

Lung Adenocarcinoma, Cryotherapy Effect Trial in Bordeaux (Cryoablation, Pembrolizumab, Pemetrexed)

Recruiting
  • Lung Adenocarcinoma
  • Cryotherapy Effect
  • Cryoablation
  • +3 more
  • Bordeaux, Gironde, France
    Institut Bergonié
Oct 29, 2021

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Carboplatin
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 14, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Arkhangel'sk, Russian Federation
  • +10 more
Dec 8, 2022

Fallopian Tube Cancer, Peritoneum Cancer, Epithelial Ovarian Cancer Trial in Miami (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Miami, Florida
    University of Miami
Dec 24, 2021

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • (no location specified)
Aug 19, 2022